Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 384781 - 384800 out of 498428 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 200 mg per 10 ml | 1 Vial, 10ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 400 mg per 20 ml | 1 Vial, 20ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AC07) tocilizumab (adm: P) | Tyenne 80 me per 4 ml | 1 Vial, 4ml, 20 mg/ml, Intravenous use, Solution for infusion, 20mg/ml , Vial, Solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid; Cytokine Release Syndrome; Arthritis, Juvenile Rheumatoid; COVID-19 virus infection; Giant Cell Arteritis | BostonOncologyArabia / FreseniusKabiAustriaGmbH |
| Saudi Arabia | (L04AH02) everolimus (adm: O) | CERTICAN 0.25MG TABLETS | 60 Blister, 0.25 mg, Oral use, Tablet, 0.25mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTIS / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AH02) everolimus (adm: O) | CERTICAN 0.75MG TABLETS | 60 Blister, 0.75 mg, Oral use, Tablet, 0.75mg , Blister, Tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | NOVARTIS / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AG04) belimumab (adm: P) | BENLYSTA 120MG POWDER FOR SOLUTION FOR INFUSION | 1 Vial, 120 mg, Intravenous use, Powder for concentrate for solution for infusion, 120mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSaudiArabiaLtd / HOSPIRA |
| Saudi Arabia | (L04AG04) belimumab (adm: P) | BENLYSTA 400MG POWDER FOR SOLUTION FOR INFUSION | 1 Vial, 400 mg, Intravenous use, Powder for concentrate for solution for infusion, 400mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | GlaxoSaudiArabiaLtd / HOSPIRA |
| Saudi Arabia | (L04AF01) tofacitinib (adm: O) | Trijan | 56 Blister, 10 mg, Oral use, Film-coated tablet, 10mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L04AF01) tofacitinib (adm: O) | Trijan | 60 Blister, 5 mg, Oral use, Film-coated tablet, 5mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | JazeeraPharmaceuticalIndustries(JPI) / TheArabPharmaceuticalManufacturingPSC(Sahab)CoLtd |
| Saudi Arabia | (L04AF01) tofacitinib (adm: O) | XELJANZ 5 mg film-coated tablet | 60 Tablet Container, 5 mg, Oral use, Film-coated tablet, 5mg , Tablet Container, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | PFIZER / PFIZER |
| Saudi Arabia | (L04AG06) alemtuzumab (adm: P) | LEMTRADA 12 MG CONCENTRATE FOR SOLUTION FOR INFUSION | 1 Vial, 1,2ml, 12 mg, Intravenous use, Concentrate for solution for infusion, 12mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | SanofiBelgium / BoehringerIngelheimPharmaGmbH&Co.KG |
| Saudi Arabia | (L04AG08) ocrelizumab (adm: P) | OCREVUS 30 MG/ML CONCENTRATE FOR SOLUTION FOR INFUSION | 1 Vial, 10ml, 300 mg, Intravenous use, Concentrate for solution for infusion, 300mg , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | F.Hoffmann-LaRocheLtd. / RocheDiagnosticsGmbH |
| Saudi Arabia | (L04AF03) upadacitinib (adm: O) | Rinvoq | 30 Bottle, 30 mg, Oral use, Prolonged-release tablet, 30mg , Bottle, Prolonged-release tablet | Retail price without vat |
$0-0 |
$0-0 |
Arthritis, Rheumatoid | ABBVIEDeutschlandGmbH / AbbVieIreland |
| Saudi Arabia | (L04AG03) natalizumab (adm: P) | Tysabri | 2 Pre-filled syringe, 1ml, 150 mg, Subcutaneous use, Solution for injection in pre-filled syringe, 150mg , Pre-filled syringe, Solution for injection in pre-filled syringe | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis | BiogenIdecB.V-Natherland / VETTERPHARMA-FERTIGUNG,GMBH&CO.KG |
| Saudi Arabia | (L04AG05) vedolizumab (adm: P) | ENTYVIO | 2 Pre-filled syringe, 108 mg, Subcutaneous use, Solution for injection, 108mg , Pre-filled syringe, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TAKEDAPHARMAA/S / VetterPharma-FertigungGmbH&Co.KG |
| Saudi Arabia | (L04AG05) vedolizumab (adm: P) | ENTYVIO | 2 Pre-filled pen, 108 mg, Subcutaneous use, Solution for injection, 108mg , Pre-filled pen, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TAKEDAPHARMAA/S / VETTERPHARMA-FERTIGUNG,GMBH&CO.KG |
| Saudi Arabia | (L04AG05) vedolizumab (adm: P) | ENTYVIO 300 mg powder for concentrate for solution for infusion | 1 Vial, 300 mg, Intravenous use, Powder for concentrate for solution for infusion, 300mg , Vial, Powder for concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Colitis, Ulcerative; Crohn Disease | TAKEDAPHARMAA/S / HOSPIRA |
| Saudi Arabia | (L04AG11) anifrolumab (adm: P, previous atc code l04aa51. new atc 4th level l04ag valid from january 2024.) | SAPHNELO 300 mg per 2 ml | 1 Vial, 2ml, 150 mg/ml, Intravenous use, Concentrate for solution for infusion, 150mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Lupus Erythematosus, Systemic | AstraZenecaAB / AstraZenecaNijmegenB.V |
| Saudi Arabia | (L04AG12) ofatumumab (adm: P) | Kesimpta | 1 Pre-filled pen, 20 mg/ml, Subcutaneous use, Solution for injection in pre-filled pen, 20mg/ml , Pre-filled pen, Solution for injection in pre-filled pen | Retail price without vat |
$0-0 |
$0-0 |
Multiple Sclerosis, Relapsing-Remitting | NOVARTISPHARMASCHWEIZAG / NOVARTISPharmaSteinAG |
| Saudi Arabia | (L04AK02) teriflunomide (adm: O) | Axyla | 28 Blister, 14 mg, Oral use, Film-coated tablet, 14mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
n/a | MSPharmaSaudi(MSPS) / ShilpaMedicareLtd |
Pages
